Alliance Pharma plc (LON:APH) insider John Dawson sold 1,100,000 shares of the business’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of GBX 70 ($0.91), for a total value of £770,000 ($1,006,141.38).

Shares of APH opened at GBX 65.40 ($0.85) on Wednesday. Alliance Pharma plc has a 1 year low of GBX 45 ($0.59) and a 1 year high of GBX 71.43 ($0.93).

The company also recently disclosed a dividend, which will be paid on Thursday, January 10th. Stockholders of record on Thursday, December 20th will be issued a dividend of GBX 0.49 ($0.01) per share. The ex-dividend date is Thursday, December 20th. This represents a dividend yield of 0.6%.

Separately, Numis Securities reaffirmed an “add” rating and set a GBX 115 ($1.50) price objective on shares of Alliance Pharma in a report on Wednesday, September 19th.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at

About Alliance Pharma

Alliance Pharma plc operates as a specialty pharmaceutical company in the United Kingdom, rest of Europe, and internationally. The company acquires, markets, and sells pharmaceutical products. It acquires the rights of established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products.

Further Reading: What are the benefits of buying treasury bonds?

Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with's FREE daily email newsletter.